Progyny, Inc. Operating CF per Share

Operating CF per Share of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating CF per Share growth rates and interactive chart. Total operating cash flow in a period divided by the weighted average number of shares outstanding. A company with $100 million in operating cash flow and 10 million weighted average shares will have operating cash flow per share of $10.


Highlights and Quick Summary

  • Operating CF per Share for the quarter ending September 29, 2021 was 0.27 (a -418.16% decrease compared to previous quarter)
  • Year-over-year quarterly Operating CF per Share increased by 256.88%
  • Annual Operating CF per Share for 2020 was 0.42 (a -2395.11% decrease from previous year)
  • Annual Operating CF per Share for 2019 was -0.02 (a -166.67% decrease from previous year)
  • Annual Operating CF per Share for 2018 was 0.03 (a -123.94% decrease from previous year)
  • Twelve month Operating CF per Share ending September 29, 2021 was 0.27 (a 56.7% increase compared to previous quarter)
  • Twelve month trailing Operating CF per Share decreased by -36.61% year-over-year
Trailing Operating CF per Share for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
0.27 0.17 0.28 0.42
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating CF per Share of Progyny, Inc.

Most recent Operating CF per Shareof PGNY including historical data for past 10 years.

Interactive Chart of Operating CF per Share of Progyny, Inc.

Progyny, Inc. Operating CF per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 0.27 -0.08 0.01
2020 0.08 0.18 0.03 0.14 0.42
2019 -0.26 0.79 0.82 -1.2 -0.02
2018 0.0 -0.1 0.0 0.03
2017 0.0 -0.12

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.